Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
110 hedge funds and large institutions have $352M invested in Dynavax Technologies in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 22 closing their positions.
77% more call options, than puts
Call options by funds: $628K | Put options by funds: $355K
9% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 34
6% less funds holding
Funds holding: 117 → 110 (-7)
9% less capital invested
Capital invested by funds: $388M → $352M (-$36.2M)
32% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 22
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.9M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$10.7M |
| 3 |
State Street
Boston,
Massachusetts
|
+$9.04M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$7.58M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$6.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$28.2M |
| 2 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$14.9M |
| 3 |
AC
Amici Capital
New York
|
-$7.88M |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$3.47M |
| 5 |
Renaissance Technologies
New York
|
-$3.06M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
JP Morgan Chase
New York
| – | -$23K | -1,180 | Closed |
|
|
TH
127
Timber Hill
Greenwich,
Connecticut
| – | -$20K | -1,017 | Closed |
|
|
AA
128
Ancora Advisors
Cleveland,
Ohio
| – | -$20K | -1,000 | Closed |
|
|
CLOS
129
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | -$8K | -400 | Closed |
|
130
BNP Paribas Financial Markets
Paris,
France
| – | -$6.52K | -333 | Closed |
|
|
TRCT
131
Tower Research Capital (TRC)
New York
| – | -$1K | -30 | Closed |
|
DVAX Hedge Fund Activity: Q1 2014 in Review
110 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q1 2014, worth a combined $352M — down 9.3% from $388M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of DVAX and 15 opened new positions — a net loss of 7 holders — while 34 trimmed existing stakes and 31 added.
The largest buyer was Fidelity Investments, adding an estimated $11.9M. The largest seller was HealthCor Management, cutting an estimated $28.2M.
- 110 institutional investors held Dynavax Technologies (DVAX) as of Q1 2014, down from 117 in Q4 2013.
- Funds reported $352M of Dynavax Technologies stock for Q1 2014, down 9.3% quarter-over-quarter.
- 15 funds opened new Dynavax Technologies positions in Q1 2014 and 22 closed out, a net change of -7 holders.
- The largest Dynavax Technologies buyer in Q1 2014 was Fidelity Investments, an estimated $11.9M added.
- The largest Dynavax Technologies seller in Q1 2014 was HealthCor Management, an estimated $28.2M sold.
Based on aggregated 13F filings for Q1 2014.